US 11571440
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
granted A61KA61K2039/5156A61K2039/5158
Quick answer
US patent 11571440 (Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion) held by Jazz Pharmaceuticals Ireland Limited expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jazz Pharmaceuticals Ireland Limited
- Grant date
- Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/5156, A61K2039/5158, A61K31/711, A61K39/0011